Metabolic imaging with FDG-PET and time to progression in patients discontinuing immune-checkpoint inhibition for metastatic melanoma

被引：0
|
作者：
Ferdinandus, J. [1 ]
Zaremba, A. [1 ]
Zimmer, L. [1 ]
Umutlu, L. [1 ]
Seifert, R. [1 ]
Barbato, F. [1 ]
Ugurel, S. [1 ]
Chorti, E. [1 ]
Gruewald, V. [1 ]
Herrmann, K. [1 ]
Schadendorf, D. [1 ]
Fendler, W. P. [1 ]
Livingstone, E. [1 ]
机构：
[1] Univ Hosp Essen, Essen, Germany
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2021年 / 48卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
OP-1075
引用
收藏
页码：S377 / S377
页数：1
相关论文
共 50 条
  • [31] Immune-checkpoint inhibition does not affect arterial [18F]FDG uptake in cancer sequential PET/CTs
    Hempfling, N.
    Weber, S.
    Buellesbach, A.
    Maier, A.
    Bojti, I.
    Gissler, M. C.
    Westermann, D.
    Meyer, P. T.
    Wolf, D.
    Bacmeister, L.
    Goetz, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S274 - S274
  • [32] The role of FDG-PET in the management of patients with metastatic melanoma: Impact on surgical decision making.
    Gulec, SA
    Faries, MB
    Lee, CC
    Glass, E
    Morton, DL
    Essner, R
    JOURNAL OF NUCLEAR MEDICINE, 2003, 44 (05) : 168P - 169P
  • [33] Monitoring of patients with metastatic melanoma treated with immune checkpoint inhibitors using PET–CT
    Antonia Dimitrakopoulou-Strauss
    Cancer Immunology, Immunotherapy, 2019, 68 : 813 - 822
  • [34] INTRACRANIAL OUTCOMES OF DUAL IMMUNE-CHECKPOINT INHIBITION AND SRS COMBINATION IN PATIENTS WITH MELANOMA AND NSCLC BRAIN METASTASES
    Vaios, Eugene
    Shenker, Rachel
    Hendrickson, Peter
    Wan, Zihan
    Niedzwiecki, Donna
    Winter, Sebastian F.
    Dietrich, Jorg
    Salama, April
    Clarke, Jeffrey
    Allen, Karen
    Mullikin, Trey
    Floyd, Scott
    Kirkpatrick, John
    Reitman, Zachary
    NEURO-ONCOLOGY, 2023, 25
  • [35] Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanoma
    Reitmajer, Markus
    Livingstone, Elisabeth
    Thoms, Kai-Martin
    Heppt, Markus V.
    Meiss, Frank
    Gesierich, Anja
    Drexler, Konstantin
    Heinzerling, Lucie
    Meier, Friedegund
    Menzer, Christian
    Schlaak, Max
    Zimmer, Lisa
    Forschner, Andrea
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2025, 23 (03): : 329 - 329
  • [36] An evaluation of FDG-PET as a predictor of metabolic response to chemotherapy in metastatic colorectal cancer patients (mCRC).
    Van Damme, N.
    De Bruyne, S.
    Mertens, J.
    Van de Wiele, C.
    Ceelen, W. P.
    Smeets, P.
    Ferdinande, L.
    Laurent, S.
    Geboes, K.
    Peeters, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [37] Inflammatory Blood Parameters as Biomarkers for Response to Immune Checkpoint Inhibition in Metastatic Melanoma Patients
    Kudura, Ken
    Nussbaumer, Lukas
    Foerster, Robert
    Basler, Lucas
    BIOMEDICINES, 2022, 10 (09)
  • [38] Sex-Related Differences in Metastatic Melanoma Patients Treated with Immune Checkpoint Inhibition
    Kudura, Ken
    Basler, Lucas
    Nussbaumer, Lukas
    Foerster, Robert
    CANCERS, 2022, 14 (20)
  • [39] Long cell-free DNA fragments predict early-progression in patients with advanced or metastatic cancer treated with immune-checkpoint inhibition
    Salas, Sebastien
    Linh Nguyen Phuong
    Garcia, Jean-Charles
    Greillier, Laurent
    Gaudy-Marqueste, Caroline
    Deville, Jean-Laurent
    Boutonnet, Audrey
    Ginot, Frederic
    Fina, Frederic
    Benzekry, Sebastien
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [40] FDG-PET imaging in detecting recurrent or metastatic colorectal cancer in patients with elevated CEA levels
    Ponzo, F
    Zhuang, HM
    Lacorte, LB
    Alavi, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 2001, 28 (08): : 1017 - 1017
12345